Novel compounds, pharmaceutical compositions and methods are disclosed for producing local anesthesia of long-duration. The compounds of this invention are multibinding compounds that comprise from 2 to 10 ligands covalently attached to a linker or linkers, each ligand being capable of binding to a ligand binding site in a voltage-gated Na+ channel to modulate the biological processes/functions thereof.
[EN] CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF<br/>[FR] ANALOGUES PEPTIDIQUES CYCLIQUES ET LEURS CONJUGUÉS
申请人:SIRENAS LLC
公开号:WO2018045245A1
公开(公告)日:2018-03-08
Provided are cyclic peptide analogs, conjugates comprising such compounds, and pharmaceutical compositions comprising such compounds and conjugates, and methods of treating cancer with such compounds and conjugates.
A herbicidal composition is provided comprising an aqueous solution of N-phosphonomethylglycine, predominantly in the form of the potassium salt thereof, at a concentration of at least 300 g a.e./l of the composition; and a surfactant component in solution or stable suspension, emulsion, or dispersion in the water, comprising one or more surfactants in a total amount of about 20 to about 300 g/l of the composition, wherein the composition has a viscosity of less than about 250 centipoise at 0° C. or a Gardner color value less than 10.
A herbicidal composition is provided comprising an aqueous solution of N-phosphonomethylglycine, predominantly in the form of the potassium salt thereof, at a concentration of at least 300 g a.e./l of the composition; and a surfactant component in solution or stable suspension, emulsion, or dispersion in the water, comprising one or more surfactants in a total amount of about 20 to about 300 g/l of the composition, wherein the composition has a viscosity of less than about 250 centipoise at 0° C. or a Gardner color value less than 10.
Manganese‐Catalyzed Mono‐<i>N</i>‐Methylation of Aliphatic Primary Amines without the Requirement of External High‐Hydrogen Pressure
作者:Jiale Ji、Yinghao Huo、Zhaowen Dai、Zhening Chen、Tao Tu
DOI:10.1002/anie.202318763
日期:2024.3.22
A synergistic strategy enables the selective synthesis of mono-N-methylated aliphaticprimaryamines, including deuterium-labelled drugs. This innovative approach combines an earth-abundant manganese catalyst with a weak base, resulting in a practical and sustainable protocol for mono-N-methylation. By effectively inhibiting the formation of formamide byproducts, it eliminates the need for external